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Abstract
Background: Adult height is inversely associated with the risk of coronary heart disease (CHD), but it is still unknown which
phase of the human growth period is critical for the formation of this association. We investigated the association between
growth in height from 7 to 13 years of age and the risk of CHD in adulthood.
Methods and Findings: The heights of almost all children born 1930 through 1976 who attended school in the
Copenhagen municipality (232,063 children) were measured annually from 7 to 13 years of age. Birth weight data were
available since 1936. Fatal and non-fatal CHD events were ascertained by register linkage until 2008 (25,214 cases). Hazard
ratios (HR) with 95% confidence intervals (CI) were estimated by Cox proportional hazards regression for height z-scores
(standard deviation units) and change in height z-scores. Height z-scores were inversely related to the risk of CHD. The
association was strongest at 7 years of age (HR= 0.91, CI 0.90–0.92 in boys and 0.88, CI 0.86–0.90 in girls) and steadily
weakened thereafter, yet it still remained at 13 years of age (HR= 0.95, CI 0.94–0.97 and 0.91, CI 0.89–0.93, boys and girls
respectively). The associations were not modified by birth weight. Independent of the age-specific risk, rapid growth was
associated with an increased CHD risk, most pronounced between 9 and 11 years in girls (HR = 1.22, CI 1.14–1.31) and
between 11 and 13 years in boys (HR= 1.28, CI 1.22–1.33) per unit increase in z-score. Adjustment for body mass index
somewhat strengthened the associations of CHD risk with height and weakened the association with growth.
Conclusions/Significance: Risk of CHD in adulthood is inversely related to height at ages 7 through 13 years, but strongest
in the youngest, and, independently hereof, the risk increased by growth velocity.
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Introduction
The association between the physical development of the child
and the adult risk of coronary heart disease (CHD) assessed by
CHD risk factor profiles as well as by the incidence of CHD in
adulthood has long attracted scientific interest [1], but the
developmental pathways are complex. Low birth weight [2,3]
and eventual short adult stature [4], which is positively correlated
with low birth weight [5], are associated with an increased adult
risk of CHD. There is also evidence that catch-up growth in height
and weight among those with low birth weight is associated with
an increased CHD risk [6]. Further, the early onset of puberty is
associated with hypertension [7] and other metabolic risk factors
of CHD [8] but also with shorter adult stature [9]. The
background of these associations is poorly understood, but it has
been suggested that low birth weight and short adult stature are
markers of environmental influences in pre- and post-natal life
which may further predispose to metabolic abnormalities [10].
The intermediate period between infancy and adolescence, i.e.
childhood, has however received little attention. The period of
childhood growth and its associations with CHD risk are
interesting both from scientific and public health point of views.
First, childhood is characterized by slow growth and its
associations with CHD risk may be different than the periods of
very rapid growth during infancy and puberty. Second, childhood
is a unique period of life from a public health point of view because
it allows for school-based screening, monitoring and intervention.
Thus we investigated how growth in height from 7 to 13 years of
age is associated with risk of CHD throughout adulthood, and
whether the association is dependent on birth weight in a large
cohort of Danish children.
Materials and Methods
The data are from the Copenhagen School Health Records
Register described in detail elsewhere [11]. In short, the study
cohort includes all children born from 1930 through 1976 and
who attended school in the Copenhagen municipality. Physicians
or nurses measured height without shoes during annual health
examinations at public and private schools. Height from 7 to 13
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years of age was computerized, and since the school year 1943
(birth year 1936) information on birth weight was available as
provided by parental report at the first school examination. The
number of participants varied from 265,490 at 8 years of age to
251,866 at 13 years of age, and the height was available at all ages
for 232,063 children (82% of all participants) (Figure 1).
Follow-up data were obtained from the National Cause of
Death Register [12] and the National Hospital Discharge Register
[13], and were linked to the anthropometric data using unique
personal identification numbers. The coverage of these registers is
very high with virtually every event recorded. CHD diagnoses
were classified according to the International Classification of
Diseases Eighth Revision (ICD-8 codes 410–414) before 1994 and
the Tenth Revision (ICD-10 codes I20–I25) thereafter. In the
Hospital Discharge Register, myocardial infarctions are recorded
with a high degree of validity [14], but in the National Cause of
Death Register, cardiovascular disease diagnoses are less accurate
[12]. Follow-up of the subjects began at 25 years of age or in 1977
when the Hospital Discharge Register was established. Age 25 was
chosen as the earliest entry age since CHD at younger age may be
because of congenital defects. The subjects were followed-up until
a fatal or non-fatal CHD event, death from other causes,
emigration or to the date of the latest register update on
December 31st, 2008, whichever came first. During the follow-
up period, 25,214 new CHD events occurred, 67% of them in
men, including 6623 fatal events. From all CHD cases, 41% were
because of acute myocardial infarction (ICD-8 code 410 and ICD-
10 code I21) and 39% because of angina pectoris (413 and I20,
respectively). The median follow-up time was 28.9 years. Of all
CHD cases, 58% (14,665 cases) occurred before 60 years of age,
and these were classified as early CHD cases in this study.
To allow the comparison of risks associated with height among
boys and girls, at different ages and by year of birth, age-, sex- and
birth cohort-specific standardized height values called height z-
scores were computed, where one standard deviation of the sex,
birth-cohort and age-specific distribution of height is the unit.
Since standard deviations of height were very similar across birth
cohorts in all ages and in boys and girls (Table S1), one unit
change of z-score can be interpreted as a change of one standard
deviation in height. The height z-scores were interpolated to exact
ages if two measurements were available or extrapolated to exact
ages if only one measurement was available. The birth weight z-
scores were calculated based on an internal reference from the
birth years of 1955 to 1960. The birth cohorts were divided into
five intervals (1930 to 1935, 1936 to 1939, 1940 to 1945, 1946 to
1952, and 1953 to 1976) [15].
Hazard ratios (HR) and 95% confidence intervals (CI) for the risk
of all CHD events (fatal or non-fatal) were first computed for height
z-scores at each age from 7 to 13 years using Cox proportional
hazards regression with age as the underlying time scale. Thus the
Cox model estimates relative hazards for covariates, such as height
z-score in these analyses, across the range of ages. Next we analyzed
the association between growth in height and the risk of CHD by
calculating differences in height z-scores between subsequent two
year intervals and computed the HRs for this change with and
without adjusting the baseline height z-score. Further we adjusted
the results for baseline body mass index (BMI). Since the z-scores
were either interpolated or extrapolated to exact ages, measures of
adjacent ages are not necessarily based on separate measures, thus
precluding the analysis of yearly changes. These analyses were also
repeated using only fatal CHD cases and CHD cases before 60 years
of age. Finally we analyzed potential non-linearity between growth
in height and CHD risk; after dividing z-scores of birth weight and
height at 7 and 13 years of age into quartiles, we estimated the HRs
for different combinations of these quartiles. We tested the
interactions between birth weight and the height quartiles using
them as categorized variables. This was done by comparing x2-
statistics according to degrees of freedom between models having all
main and interaction effects with models that only included main
effects.
Year of birth was included as a continuous variable in all models
to account for any linear association between year of birth and
CHD risk within the five birth cohorts. Birth cohort was also used
as a stratum variable in the models thus allowing different baseline
hazards for each of them. Because growth is different in boys and
girls, separate analyses were conducted by sex. The exception was
the analyses of growth between birth weight and height at 7 and
13 years of age since the number of cases in some categories was
too small for sex-specific analyses; in these analyses sex was used as
a stratum variable. Stata statistical software, version 10.1, was used
to conduct the analyses.
Since the study is entirely based on register data, only an
approval by the Danish Data Protection Agency was required, and
it was obtained.
Figure 1. Number of children at each age, number of children
measured also at the subsequent age and new children at the
subsequent age.
doi:10.1371/journal.pone.0030476.g001
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Results
Boys were nearly 1 cm taller than girls until age 11 at which age
the difference in height disappeared and thereafter girls were slightly
taller (Table 1). Growth was most rapid between 11 and 12 years of
age in girls (6.2 cm) and between 12 and 13 years of age in boys
(5.8 cm). From 10 to 12 years of age, the standard deviation was
larger in girls than in boys whereas the opposite was true at age 13. A
clear increase in the mean height across the birth years was observed
(Table S1). When calculated using year of birth as a continuous
measure, mean height increased 1.1 cm per decade in boys and
1.0 cm per decade in girls at the age of 7, and the mean increase was
1.5 cm per decade in both boys and girls at the age of 13.
Height was inversely associated with CHD risk at all ages in
boys and girls (Table 2). When adjusted only for birth year (Model
1), the association was strongest at 7 years of age (HR=0.91 in
boys and 0.88 in girls) and weakened thereafter, with HR values
approaching 1, but it still remained present at 13 years of age
(HR=0.95 and 0.91, respectively). When only CHD cases before
60 years of age or fatal CHD cases were analyzed, the age pattern
was similar but the risks were systematically stronger than for all
CHD cases in boys and girls (Table S2). We then adjusted the
results additionally for birth weight in the sub-cohort where this
information was available (Model 2) and found that HR values
were very similar to those without this adjustment. Finally we
adjusted the results for BMI (Model 3) and found that the
association became stronger; this effect was stronger at older ages
and thus the age pattern was weaker in the BMI adjusted results,
especially in boys.
Rapid growth in height between 7 and 9 years of age, measured
as change in relative height between these two ages, was associated
with an increased CHD risk in boys and girls (HR=1.11 and 1.17
for 1-unit change in height z-scores, respectively) (Table 3). In
boys, the CHD risk increased steadily and was strongest for growth
between 11 and 13 years of age (HR=1.28). In girls this
association was strongest between 9 and 11 years of age
(HR=1.22) and then disappeared when adjusted only for birth
year (Model 1). When only CHD cases before 60 years of age or
fatal CHD cases were analyzed, the strongest associations were
also seen between 11 and 13 years of age in boys and between 9
and 11 years of age in girls, but in boys the associations were
stronger than for all CHD cases (Table S3). Adjustment for height
(Model 2) and BMI (Model 3) at baseline attenuated these
associations, but growth from 9 to 11 and 11 to 13 years of age in
boys and from 11 to 13 years of age in girls was still statistically
significant.
Next, we analyzed whether the association between height z-
score at age 7 and CHD risk varied according to birth weight z-
score. The risk of CHD steadily increased from the tallest to the
shortest quartile of height in all quartiles of birth weight (Figure 2).
Table 1. Number of participants, means and standard deviations (SD) of birth weight and of height from 7 to 13 years of age.
Boys Girls
N mean SD N mean SD
Birth weight (kg) 104,494 3.42 0.614 108,875 3.29 0.599
Height at age 7 (cm) 131,910 123.4 5.43 129,117 122.5 5.40
Height at age 8 (cm) 134,143 127.6 5.53 131,347 126.6 5.52
Height at age 9 (cm) 132,679 132.9 5.82 130,223 131.9 5.83
Height at age 10 (cm) 130,943 138.0 6.07 128,936 137.2 6.23
Height at age 11 (cm) 129,994 142.8 6.38 128,201 142.8 6.83
Height at age 12 (cm) 128,478 147.8 6.94 127,056 149.0 7.35
Height at age 13 (cm) 126,297 153.6 7.88 125,569 154.9 7.20
doi:10.1371/journal.pone.0030476.t001
Table 2. Hazard ratios (HR) with 95% confidence intervals (CI) for CHD incidence per 1 unit increase in z-scores of height from 7 to
13 years of age.
Boys Girls
Model 1 Model 2 Model 3 Model 1 Model 2 Model 3
HR 95% CI HR 95% CI HR 95% CI HR 95% CI HR 95% CI HR 95% CI
Age 7 0.91 0.90–0.92 0.91 0.89–0.93 0.90 0.89–0.91 0.88 0.86–0.90 0.88 0.85–0.90 0.87 0.85–0.89
Age 8 0.91 0.90–0.92 0.91 0.89–0.93 0.89 0.88–0.91 0.89 0.87–0.91 0.87 0.85–0.90 0.88 0.86–0.90
Age 9 0.92 0.90–0.93 0.92 0.90–0.94 0.89 0.88–0.91 0.89 0.87–0.91 0.88 0.85–0.91 0.88 0.86–0.90
Age 10 0.92 0.91–0.93 0.92 0.90–0.94 0.89 0.88–0.91 0.90 0.88–0.92 0.88 0.86–0.91 0.88 0.86–0.90
Age 11 0.93 0.91–0.94 0.93 0.91–0.95 0.90 0.88–0.91 0.91 0.89–0.93 0.90 0.87–0.93 0.89 0.87–0.91
Age 12 0.93 0.92–0.95 0.94 0.92–0.96 0.90 0.88–0.91 0.92 0.90–0.94 0.91 0.88–0.93 0.89 0.87–0.91
Age 13 0.95 0.94–0.97 0.96 0.94–0.98 0.91 0.89–0.92 0.91 0.89–0.93 0.90 0.87–0.92 0.88 0.86–0.90
Model 1 = adjusted for birth cohort; Model 2 = adjusted for birth cohort and birth weight in a sub-cohort; Model 3 = adjusted for birth cohort and BMI at baseline.
doi:10.1371/journal.pone.0030476.t002
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There was no statistically significant (p = 0.26) interaction among
height z-score quartiles at age 7 and birth weight z-score quartiles
on the risk of CHD.
Next we conducted the same type of analysis between height z-
scores at ages of 7 and 13 (Figure 3). This analysis showed that the
highest risk was in those participants who were in the shortest
height z-score quartile at 7 years of age and in the tallest quartile at
13 years of age (HR=1.82, 95% CI 1.36–2.42), but otherwise no
evidence of an interactive effect was seen. There was not a
statistically significant overall interaction effect among height z-
score quartiles at 7 and 13 years of age (p = 0.07).
We finally tested the heterogeneity of the associations of height
and growth with CHD incidence over the birth cohorts. Because
we found that the HRs were slightly stronger for CHD cases
before 60 years of age than for all CHD cases, we conducted these
analyses only for CHD cases before 60 years of age to account for
differences in follow-up time among the birth cohorts. We found
that the interactions between birth cohort and height at different
ages were not statistically significant (Table S4). Growth from 7 to
9 years of age showed a statistically significant interaction with
birth cohort in boys (p = 0.002) which was because of relatively
high HRs in the cohort born 1940 to 1945 (HR 1.48 95% CI
1.27–1.72). For growth from ages 11 to 13 years, a relatively high
HR in the cohort born 1936 to 1939 was found (HR 1.56 95% CI
1.35–1.79), but the overall interaction was not statistically
significant (p = 0.158). Otherwise, the HRs were very similar in
all birth cohorts and the interactions between birth cohort and
growth were not statistically significant (Table S5). Thus these
results suggested that the associations or height and growth with
CHD incidence later in life are largely similar across the birth
cohorts.
Discussion
In this large longitudinal cohort we found that shorter stature in
children from age 7 to 13 years was associated with an increased
risk of CHD in adulthood, and these associations were not
modified by birth weight. Height z-scores predicted the later risk of
CHD with approximately the same effect size as did BMI z-scores
in these same data [15], but the direction of the effect and changes
in strength of the associations across the age groups were opposite.
The associations between height and CHD showed a clear age
pattern: they were strongest at the age of 7 and decreased until the
age of 13 in both boys and girls. This pattern was partly because of
the effect of BMI; when the results were adjusted for BMI the
association between height and further CHD incidence become
stronger because of correlation between height and BMI (r from
0.18 to 0.30), and this change was more visible at older ages. These
Table 3. Hazard ratios (HR) with 95% confidence intervals (CI) of CHD incidence for 1 unit change in z-scores between 7 and 13
years of age.
Boys Girls
Model 1 Model 2 Model 3 Model 1 Model 2 Model 3
HR 95% CI HR 95% CI HR 95% CI HR 95% CI HR 95% CI HR 95% CI
Age 7 to Age 9 1.11 1.04–1.18 1.05 0.98–1.12 1.02 0.96–1.09 1.17 1.08–1.28 1.09 1.00–1.19 1.08 0.99–1.17
Age 9 to Age 11 1.23 1.15–1.32 1.18 1.10–1.27 1.13 1.05–1.21 1.22 1.14–1.31 1.16 1.08–1.25 1.14 1.06–1.22
Age 11 to Age 13 1.28 1.22–1.33 1.24 1.19–1.30 1.13 1.05–1.21 1.01 0.95–1.08 0.97 0.91–1.04 0.99 0.92–1.05
Model 1: Adjusted for birth cohort; Model 2: Adjusted for birth cohort and height z-score at baseline; Model 3: Adjusted for birth cohort and height z-score and BMI at
baseline.
doi:10.1371/journal.pone.0030476.t003
Figure 2. Hazard ratios of CHD risk by quartiles of height z-score at age 7 and birth weight z-score in the pooled data of men and
women.
doi:10.1371/journal.pone.0030476.g002
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findings strongly suggest that further investigations of the
underlying biological processes that the growth-CHD association
is driven by are warranted. The associations were slightly stronger
for CHD cases before 60 years of age and the fatal events than for
all fatal and non-fatal events together. The associations are
measured on the multiplicative hazard ratio scale, which is
sensitive to the baseline hazards - the lower it is the stronger the
association for a given excess incidence rate. Whether the growth
patterns are truly differently associated with the various manifes-
tations of CHD, ranging from first diagnosis of angina pectoris
through immediate death, is an open question beyond the scope of
our present study.
The association between short adult stature and increased CHD
risk has been known since the 1980s [16] and has been replicated
in numerous studies since then [4]. However studies on the
association between height in childhood and later CHD risk are
sparse. In the Hertfordshire study it was reported for the first time
that low birth weight in men and women as well as low weight at
one year of age in males was associated with a higher risk of
cardiovascular diseases [17], and thereafter it has been found in
several studies that low birth weight is associated with increased
risk of cardiovascular disease [3] as well as its risk factors [2]. In
another UK cohort of children 2 to 14 years of age at baseline, leg-
length and height were inversely associated with CHD mortality in
adulthood [18].
Our results show that it is necessary to disentangle the effects of
a generally slow growth trajectory leading to short stature in adults
and a fast growth trajectory during late childhood; both are
associated with increased risk of later CHD, and are therefore
masking the effects of each other in the final stature. Thus the
decreasing strength of the association between height and the risk
of CHD across childhood probably reflects a mixture of opposing
effects. The inverse association between childhood height and risk
of CHD in adulthood may be diluted by the opposite effect of
rapid growth that increases the CHD risk. The tallest boys and
girls at 13 years of age thus appear to be a heterogeneous group
with regard to CHD risk. Those who were taller-than-average at 7
years of age and remained tall had the lowest CHD risk. In
contrast, those who were shorter-than-average at 7 years of age
and then grew and became taller-than-average at 13 years of age
had an increased CHD risk, which even exceeded the risk of the
children who remained shorter-than-average between 7 and 13
years of age. Rapid growth was associated with higher BMI, but
the association between rapid growth and CHD risk remained
even when adjusting the results for baseline BMI.
Interestingly, rapid growth between 11 and 13 years of age in
boys and between 9 and 11 years of age in girls showed the
strongest association with increased CHD risk. These ages closely
coincide with the timing of puberty in the Danish population both
measured as sexual maturation [19] and as the onset of pubertal
growth spurt [20]. In this same cohort, the average age at the onset
of pubertal growth spurt was 12.2 years in boys born from 1930 to
1940 and decreased to 11.8 years in those born from 1965 to 1970
whereas in girls the ages were 10.4 and 10.2 years, respectively
[20]. A Finnish study has also shown that rapid growth during
these periods correlates closely with early sexual maturation [21].
Thus it is likely that children in our cohort who experienced rapid
growth at these ages also had an early onset of puberty. This is
consistent with the finding of high risk of CHD in the boys and
girls who were in the shortest height quartile at 7 years of age but
in the tallest quartile at 13 years of age. Previous studies have
shown that early onset of puberty is associated with the emergence
of several risk factors for CHD including hypertension [7], obesity
[22], adverse blood lipid profile [8] and high levels of insulin [23]
in adulthood. Our study thus suggests that the growth rate during
the age of pubertal development is associated with increased risk of
CHD in adulthood, and this association is very similar in men and
women despite their different timing of puberty.
It is noteworthy that rapid growth and increased CHD risk was
seen already between 7 and 9 years of age in both boys and girls
thus well preceding the onset of puberty. A Finnish study found
that participants diagnosed with hypertension at 63 years of age
had a lower birth weight and had showed catch-up growth in
height and weight until 11 years of age when compared to
normotensive men and women. The individuals, however, who
were newly diagnosed as hypertensive in the clinical examination
showed a different growth pattern since they had low birth weight,
but did not show catch-up growth [24]. In this same Finnish
cohort it was also found that in females short length at birth was
associated with higher risk of CHD in adulthood, and this
association was strongest in those women who had experiences
catch-up growth until 7 years of age [25].
Figure 3. Hazard ratios of CHD risk by quartiles of height z-score at age 7 and 13 in the pooled data of men and women.
doi:10.1371/journal.pone.0030476.g003
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We found no evidence supporting that only children with a low
birth weight combined with later rapid growth in height have a
higher CHD risk; the association between height in childhood and
later CHD risk was largely independent of birth weight. This result
is consistent with a previous Finnish study, which found no
evidence of catch-up growth from 2 to 10 years of age in the
persons who had had coronary event in adulthood [6]. The results
rather suggest that the height growth velocity in childhood carries
a risk for CHD independent of birth weight. These associations
likely reflect the combined effects of nutritional, environmental,
genetic and hormonal factors, such as the secretion of insulin-like
growth factor, on growth [26]. For example, it has been found that
leg length in childhood is more strongly associated with CHD risk
than trunk length, which may be because leg length is a more
sensitive indicator of environmental factors than trunk length [18].
There is also evidence based mainly on Finnish studies that growth
in utero and infancy may be associated with the proportion of lean
body mass and lipid metabolism in adulthood [10].
The association between short stature-to-age in childhood and
later CHD risk may at least partly reflect the role of socio-
economic factors, since it is well known that low socioeconomic
position in childhood is associated with shorter adult stature [27]
and that clear socioeconomic differences in CHD risk are present
in Northern-Europe and the USA [28]. We did not have access to
information on parental socio-economic position, so we could not
directly test this hypothesis. However, a previous Nordic study
found an association between adult stature and CHD risk within
discordant twin pairs suggesting that socio-economic background
cannot explain the association [29]. Further, we found that the
association between stature and CHD was similar across birth
cohorts despite a clear secular trend in height and improvements
in the standard of living in Danish society across the birth cohorts.
Taken together, these results suggest that the association between
height and CHD risk is not strongly modified by socioeconomic
position, and we neither find reasons to suspect that rapid growth
in childhood is associated with low socio-economic position.
Moreover, the study design and completeness of follow-up make it
very unlikely that any socioeconomic selection bias exists.
The biological pathways underlying the association of CHD
incidence with growth are still largely unknown. In addition to the
above mentioned hypotheses on the role of nutritional, metabolic,
hormonal and socioeconomic factors as mediators of this
association, there are also other possible explanations. It has been
suggested that short stature might be a CHD risk factor itself since
it correlates with narrow coronary arteries, which may further
predispose to CHD [30]. However our results did not give support
for this hypothesis since we found that the association between
height at 13 years of age and further CHD incidence depended on
the growth velocity from 7 to 13 years of age. Further, there may
be other mechanisms that are currently unknown. To answer these
types of questions data sets containing information on growth in
childhood and detailed metabolic as well as other biological
measurements in adulthood are required. Future research can be
undertaken to investigate these potentially mediating pathways in
depth by using information from detailed examinations in much
smaller subgroups of individuals selected on the basis of various
growth patterns in childhood.
Our study has several strengths, but also limitations. We used a
very large population-based cohort with annual height measures
from 7 through 13 years of age. The health examinations were
performed at all public and private schools and thus cover virtually
every schoolchild in the Copenhagen municipality born from 1930
to 1976. Our follow-up data cover also all study participants
because of universal health care system in Denmark. Thus, it is
very unlikely that any selection bias exists at baseline or during
follow-up. In the present cohort, we lack information on
conventional risk factors for CHD, and it will be a task for future
studies to elaborate which metabolic or other biological factors
may underlie the observed associations between childhood growth
and further CHD risk. Further since we do not have any
measurements of sexual maturation, such as age at the onset of
menarche, and we cannot determinate peak growth velocity for
late mature children our results on the associations between timing
of puberty and further CHD incidence can be regarded only
tentative. It is also noteworthy that our study population represents
an ethnically homogeneous Caucasian population with tall
average stature [31]. There is little research on the associations
between childhood height and CHD risk in other ethnic groups.
However, for adult stature the association was very similar in a
study of Korean men [32] to that found in studies conducted in
adult Caucasian populations [4] suggesting that the association
between growth and CHD risk would be present also in other
ethnic groups as well.
To summarize, we found that shorter stature in childhood was
associated with increased CHD risk in adulthood, that it grew
weaker with age, and that the association was independent of birth
weight. Rapid pre-pubertal growth, but especially rapid growth
close to puberty, was associated with increased CHD risk,
demonstrating the importance of physical development of the
child for the risk. Physical development in childhood thus captures
important information on the childhood environment, such as
socio-economic factors and nutrition, which are important for
further cardio-vascular health. Thus our results support the
importance of optimal living conditions in childhood for a future
healthy life. Unraveling the biological pathways of this association
and the exploration of the utility of the association in prevention of
CHD are tasks for future research.
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